Rochester,NY 7/13/2009 11:11:43 PM
News / Finance

Mid Morning Stock Report - HEB - Biotech Stock Mailbag: Spectrum - Sourced WhisperFromWallStreet.com

Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. HEB

"Spectrum Pharmaceuticals(SPPI Quote) raised $21 million right before the FDA is supposed to decide on the approval of Zevalin. That's a bad sign, right?"

Normally, I'd agree, but in this case, I'd say that Spectrum's management was taking rightful advantage of what has been a lucky, albeit fundamentally unjustified, run-up in the company's stock price since May.

In that time, the stock has jumped from $2.50 to almost $8. Management would be criminally negligent if it didn't pounce on the opportunity to sell stock and raise cash. So, I say bravo, Spectrum.

ABOUT - Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc., a biopharmaceutical company, engages in the clinical development, manufacture, marketing, and distribution of new drug therapies for the treatment of viral and immune based chronic disorders. The company's products include Alferon N Injection for the treatment of genital warts; and Ampligen, an experimental drug that is in human clinical development for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome, HIV, renal cell carcinoma, and malignant melanoma. Its products also comprise Alferon LDO, a low-dose, oral liquid formulation of natural alpha interferon for influenza and viral diseases, which is in the early stage of development; and Oragens for the treatment of viral diseases and disorders of the immune system. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.

Last Trade:    2.03
Day's Range:  1.95 - 2.10
52wk Range:   0.25 - 4.54
Volume:         1,348,029

   
During 2009 we have sent 40+ alerts with an average gain of over 80%.  Below are a few alerts sent only to our whisperfromwallstreet.com members.

SPNG 1800%

AMNG 241%

RKBD 300%

UTRM 169%

TLLE 266%

Sign up now to receive
free stock alerts


Please Read Our Disclaimer at http://whisperfromwallstreet.com/disclaimer.php